Gladstone maintains an active and diverse intellectual property (IP) portfolio around technologies, novel approaches to treating disease, and specific therapies.
Several options for licensing Gladstone IP are available to both new start-ups, established companies, and research institutions.
Contact the Corporate Liaison and Ventures Team for more information on licensing opportunities.
Patents
Additional technologies not listed here may be available for discussion under confidential disclosure agreement. Contact our legal team for licensing inquiries.
| TITLE | PATENT OR PUBLICATION NUMBER |
|---|---|
| Method of Determining Cellular Protein Homeostasis | |
| Compositions and Methods for Reactivating Latent Immunodeficiency Virus | |
| In Vitro Assays for Inhibition of Microglial Activation | |
| Chemical Reprogramming to Generate Neuronal Cells | |
| Methods of Treating Disease by Metabolic Control of T-Cell Differentiation | |
| Generation of Expandable Cardiovascular Progenitor Cells | |
| Methods and Compositions for Treating Obesity and/or Diabetes and for Identifying Candidate Treatment Agents | |
| Compositions and Methods for Reactivating Latent Immunodeficiency Virus | |
| Methods for Modulating Genome Editing | |
| Reversion of Primed Pluripotent Stem Cells to Naive Pluripotent Stem Cells | |
| Methods and Compositions for Producing Pancreatic Beta Cells | |
| Methods for Treating a Cytomegalovirus Infection | |
| In Vitro Methods of Differentiating Stem Cells into Neurons and Neurons Generated Using the Same | |
| Methods for Inducing Cardiomyogenesis | |
| Detection of Genome Editing | |
| Small Molecule Cellular Reprogramming to Generate Neuronal Cells | |
| Automated Robotic Microscopy Systems | |
| Compositions, Systems, and Methods for Gene Expression Noise Drug Screening and Uses Thereof | |
| Compositions and Methods of Use Thereof for Identifying Anti-Viral Agents | |
| Dual-Color HIV Reporter System for the Detection of Latently Infected Cells | |
| Substituted Benzoxazine and Related Compounds | |
| Compositions and Methods for Treating Dengue Virus Infection | |
| Generating Definitive Endoderm and Pancreatic Progenitor Cells | |
| Generating Hepatocytes | |
| Methods of Modulating Smooth Muscle Cell Proliferation and Differentiation | |
| Methods of Promoting CNS Neuronal Repair by Inhibiting LRP-1 | |
| Compositions and Methods for Regulating Glucose Metabolism | |
| Methods of Generating Neural Stem Cells | |
| Methods for the Reactivation of Latent HIV Using Cytosine Methylation Inhibitors and NF-ΚB Activators | |
| Compositions and Methods for Treating Neurological Disorders | |
| Methods of Treating Neurodegenerative Disease | |
| Treatment of HIV-1 Infection and AIDS | |
| Methods and Compositions for Reducing Amyloid Beta Levels | |
| Use of SIRT1 Activators or Inhibitors to Modulate an Immune Response | |
| Methods of Modulating Lipid Concentrations in Eukaryotic Cells | |
| Method for Identifying Agents Capable of Inhibiting APOBEC3C Activity in HIV-Infected Cells | |
| Small Molecule Inhibitors of Kynurenine-3-Monooxygenase | |
| Method of Increasing Cathepsin B-Induced Cleavage of Amyloid-Β Peptides | |
| Inhibitors of Kynurenine-3-Monooxygenase | |
| Methods and Compositions for the Synergistic Activation of Latent HIV | |
| Methods of Treating Smooth Muscle Cell Disorders | |
| Diacylglycerol O-Acyltransferase 2α (DGAT2α) | |
| Methods for Treating Lentivirus Infections | |
| Methods and Compositions for Reducing Amyloid Beta Levels | |
| Immunogenic Compositions Comprising HIV-1 Acetylated Tat Polypeptides | |
| Methods of Detecting Neurological Disorders | |
| Acyl CoA: Cholesterol Acyltransferase (ACAT-2) | |
| Robotic Microscopy Systems | |
| Histone Deacetylase and Methods of Use Thereof | |
| Virion-Based Fusion Assay | |
| Mouse Model of Chronic Heart Failure and Coronary Atherosclerosis Regression |